SESSION TITLE: Pulmonary Vascular Disease
SESSION TYPE: Case Report Poster
PRESENTED ON: Sunday, April 17, 2016 at 11:45 AM - 12:45 PM
PURPOSE: Pulmonary hypertension (PH) is a progressive fatal disease requiring aggressive specific therapy. As parenteral prostanoid administration with external pumps is associated with local side effects for subcutaneous treprostinil and rare but severe catheter-related infections for intravenous prostanoids, the availability of an implantable pump for intravenous treprostinil represents a significant progress. This surgical approach requires careful interdisciplinary interaction as PH patients carry significantly elevated anesthesia risks, especially with such relevant comorbidities.